Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results
Appointed Dr. Amanda Banks, a tenured physician and biotech leader, as Chief Development Officer to lead clinical strategy and executionExpanded...
Day: August 13, 2024
Apollomics Announces Positive Preliminary Data of Vebreltinib in Patients with Non-CNS MET Fusion Solid Tumors from its Phase 2 SPARTA Trial
43% overall response rate: Six confirmed responses (including one complete response in metastatic non-small cell lung cancer and five partial...
Tonix Pharmaceuticals to Present at the Summer 2024 Virtual Investor Summit
CHATHAM, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated...
Teknova Introduces Proprietary Express-Tek℠ Production Service and Expanded Manufacturing Grade Options to Expedite Novel Therapy Development
Express-TekSM Production enables customers to have their products enter production in days instead of weeks, significantly shortening turnaround time New...
ProPhase Labs Announces Collaboration with Forward Healthcare Consultants to Aid in the Commercialization of its Billion Dollar Potential BE-Smart Esophageal Cancer Test
GARDEN CITY, NY, Aug. 13, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next-generation biotech, genomics, and diagnostics...
Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
Announced positive survival data from the phase 2 randomized controlled clinical trial of CAN-2409 in borderline resectable pancreatic cancerPresented positive...
Ocuphire Pharma Announces Financial Results for Second Quarter 2024 and Provides Corporate Update
VEGA-3 Phase 3 Study of Phentolamine Ophthalmic Solution in Presbyopia is Recruiting Patients with Top-Line Data Expected in 2025 LYNX-2...
PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results
PRINCETON, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage...
BioVie to Present Overview of Bezisterim Clinical Data on Longevity at 11th Aging Research and Drug Discovery Meeting
Presentation to showcase potential impact of bezisterim on biological age, gene expression and measures of aging-related diseases from growing body...
Optimi Health and Psyence Biomedical Sign Non-Binding Letter of Intent to Advance Global Psilocybin Drug Development
Vancouver, British Columbia and New York, New York--(Newsfile Corp. - August 13, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX:...
Therma Bright Welcomes Medical & Pharmaceutical Veteran Michael Raimondo to Its Advisory Board
New Advisory Board Member Will Initially Focus On Venowave Sales & Business DevelopmentToronto, Ontario--(Newsfile Corp. - August 13, 2024) -...
FendX Announces Publication of Results of Its Pathogen Detection Nanotechnology
AI-enhanced nanotechnology demonstrated highly reliable pathogen detectionOakville, Ontario--(Newsfile Corp. - August 13, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF)...
Sinch AI Used to Safely Pre-Triage Patients
STOCKHOLM, Aug. 13, 2024 /PRNewswire/ -- Sinch (Sinch AB (publ) – XSTO: SINCH), which is pioneering the way the world...
SPECTUM DYNAMICS MEDICAL AND DEEPDENSE MEDICAL ENTER INTO A PARTNERSHIP TO REVOLUTIONIZE AI IN CARDIAC AND SPINE DISEASE IMAGING AND TREATMENT
SARASOTA, Fla., Aug. 13, 2024 /PRNewswire/ -- Spectrum Dynamics Medical, a leading innovator in digital SPECT-CT imaging solutions, announced that...
Cantargia Presents the Interim Report for Q2 2024 on August 28 at 3.00 p.m.
LUND, SE / ACCESSWIRE / August 13, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) will publish the company's...
Defence Therapeutics Collaboration Agreement with Orano to Develop the Next Generation of Targeted Radio-Immunotherapy for Cancer Advances
Vancouver, British Columbia--(Newsfile Corp. - August 13, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or...
New Scientific Article on NeuroRestore ACD856 and its Improved Cognition and Disease Modification of Alzheimer’s Disease
STOCKHOLM, SE / ACCESSWIRE / August 13, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical...
Evotec Announces Strong Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb
Key scientific achievements drive the expansion of the pipeline of molecular glue degradersPerformance-based and programme-based payments of in total US$...
Kootenai Health Notifies Individuals of a Data Breach
COEUR D'ALENE, Idaho, Aug. 12, 2024 /PRNewswire/ -- Kootenai Health and its subsidiaries Kootenai Clinic, Kootenai Outpatient Surgery and Kootenai Outpatient Imaging...
Kootenai Health Notifies Individuals of a Security Incident
COEUR D'ALENE, Idaho, Aug. 12, 2024 /PRNewswire/ -- Kootenai Health and its subsidiaries Kootenai Clinic, Kootenai Outpatient Surgery and Kootenai Outpatient Imaging...